

imon D. Kyle1, Madeleine E.D. Hurry2, Richard Emsley3, Antonia Marsden4, Ximena Omlin1, 
Amender Juss5, Kai Spiegelhalder6, Lampros Bisdounis1, Annemarie I Luik1,7, Colin A. 
Espie1,8, Claire E. Sexton9,10 














Rotterdam, Netherlands 
8. Big Health Ltd., London, UK 
9. Oxford Centre for Human Brain Activity, Wellcome Centre for Integrative 





Sleep and Circadian Neuroscience Institute, Nuffield Department of Clinical Neurosciences, 
University of Oxford 

© Sleep Research Society 2020. Published by Oxford University Press on behalf of the Sleep 
Research Society. All rights reserved. For permissions, please e-mail 
journals.permissions@oup.com. 


 
 
 























 
 
 
 
 






A ccepted M anuscript 
 
 
 
 
 
 








A ccepted M anuscript 
 
 
 

























 
 
 
 

























 
 
 
 

























 
 
 
 



























 
 
 
 





















 
 
 
 
 
 
 



























 
 
 

























 
 
 
 
























 
 
 
 
 























 
 
 
 
 























 
 
 
 
 






















 
 
 
 
 
 

























 
 
 
 
 
 























 
 
 
 
 






















 
 
 
 
 
 



























 
 
 
 
 


























 
 
 
 




























 
 
 













A ccepted M anuscript 
 






 
 
 
 
 













A ccepted M anuscript 
 



 
 
 




















 
 
 
 
 
 
 




disorders and other disorders of the brain in Europe 2010. Euro Neuropsych 
2011; 21: 655-79. 
4. Kyle SD, Crawford MR, Morgan K, Spiegelhalder K, Clark AA, Espie CA. The 
Glasgow Sleep Impact Index (GSII): a novel patient-centred measure for 
assessing sleep-related quality of life impairment in insomnia disorder. Sleep 
Med 2013; 14: 493-501. 
3. Kyle SD, Espie CA, Morgan K. “… Not just a minor thing, it is something 
major, which stops you from functioning daily”: quality of life and daytime 
functioning in insomnia. Behav Sleep Med 2010; 8: 123-40. 
A ccepted M anuscript 
insomnia. Sleep 2007; 30: 1205-11. 
analysis. Front Psychol 2019; 10: 101. 
impairments of primary insomnia. Sleep Med Rev 2010; 14: 47-60. 

 
 
subjective symptomatology and objective neuropsychological performance in 
functions in insomnia disorder: A systematic review and exploratory meta- 
7. Shekleton JA, Rogers NL, Rajaratnam SM. Searching for the daytime 
9. Fortier-Brochu É, Beaulieu-Bonneau S, Ivers H, Morin CM. Insomnia and 
daytime cognitive performance: a meta-analysis. Sleep Med Rev 2012; 16: 
83-94. 



performance in insomnia disorder: The impact of hyperarousal and short 
sleep duration. J Sleep Res 2018; 27: e12747. 

 
 
 
 
 
 
 
 
 
 
 
 









dementia: a systematic review and meta-analysis. Sleep Med Rev 2018; 40: 
4-16. 
Alzheimer’s disease: a systematic review and meta-analysis. Sleep 2016; 40: 
zsw032. 
Neuroimaging insights into insomnia. Curr Neurol Neurosci Reports 2015; 15: 
9. 
A ccepted M anuscript 
2017; 33: 14-23. 
an automated media-rich web application. Sleep 2012; 35: 769-81. 
Sleep Med Rev 2018; 39: 37-51. 
 
17. Aasvik J, Stiles TC, Woodhouse A, Borchgrevink P, Inge Landrø N. The Effect 
of Insomnia on Neuropsychological Functioning in Patients with Comorbid 
Symptoms of Pain, Fatigue, and Mood Disorders. Arch Clin Neuropsychol 
19. Espie CA, Kyle SD, Williams C, et al. A randomized, placebo-controlled trial of 
online cognitive behavioral therapy for chronic insomnia disorder delivered via 
18. Herbert V, Kyle SD, Pratt D. Does cognitive behavioural therapy for insomnia 
improve cognitive performance? A systematic review and narrative synthesis. 
20. Kyle SD, Hurry ME, Emsley R, et al. Effects of digital Cognitive Behavioural 
Therapy for Insomnia on cognitive function: study protocol for a randomised 
controlled trial. Trials 2017; 18: 281. 

Condition Indicator: a clinical screening tool to evaluate insomnia disorder. 
BMJ Open 2014; 4: e004183. 

 
 
 
 
 
 
 
 
 
 
 
 

scale (DFSAS): a new insomnia-specific measure to probe daytime 
impairment and poor sleep attributions. In Sleep 2010; 33: A192-A193. ONE 
WESTBROOK CORPORATE CTR, STE 920, WESTCHESTER, IL 60154 
USA: AMER ACAD SLEEP MEDICINE. 

for 
Psychopharmacology consensus statement on evidence-based treatment of 
insomnia, parasomnias and circadian rhythm disorders. J Psychopharmacol 
2010; 24: 1577-601. 


25. Freeman D, Sheaves B, Goodwin GM, et al. The effects of improving sleep on 
mental health (OASIS): a randomised controlled trial with mediation analysis. 
Lancet Psych 2017; 4: 749–58 
therapy for insomnia on health, psychological well-being, and sleep-related 
quality of life: a randomized clinical trial. JAMA Psych 2019; 76: 21-30. 


research. Psych Res 1989; 28:193-213. 
Psychsom Res 1995; 39: 315-25. 


Pittsburgh Sleep Quality Index: a new instrument for psychiatric practice and 
30. Smets EM, Garssen B, Bonke BD, De Haes JC. The Multidimensional Fatigue 
Inventory (MFI) psychometric qualities of an instrument to assess fatigue. J 





32. Broadbent DE, Cooper PF, FitzGerald P, Parkes KR. The cognitive failures 
questionnaire (CFQ) and its correlates. Br J Clin Psychol 1982; 21: 1-6. 

 
 
 
 
 
 
 
 
 
 
 
 
 





35. Kyle SD, Morgan K, Spiegelhalder K, Espie CA. No pain, no gain: an 
exploratory within-subjects mixed-methods evaluation of the patient 
experience of sleep restriction therapy (SRT) for insomnia. Sleep Med 2011; 
12: 735-47. 
38. Christensen H, Batterham PJ, Gosling JA, et al. Effectiveness of an online 
insomnia program (SHUTi) for prevention of depressive episodes (the 
GoodNight Study): a randomised controlled trial. Lancet Psych 2016; 3: 333- 
41. 
36. Boutron I, Altman DG, Moher D, Schulz KF, Ravaud P, DJ C, et al. 
CONSORT Statement for Randomized Trials of Nonpharmacologic 
Treatments: A 2017 Update and a CONSORT Extension for 
Nonpharmacologic Trial Abstracts. Ann Intern Med 2017; 167: 40 


functioning. Sleep 2014; 37: 107-16. 
Neuropsych 2006; 21: 487-494. 
Cog Neuropsych 2016; 21: 539-64. 
 

 

40. Shekleton JA, Flynn-Evans EE, Miller B, et al. Neurobehavioral performance 
impairment in insomnia: relationships with self-reported sleep and daytime 
39. Middleton L, Denney DR, Lynch SG, Parmenter B. The relationship between 
perceived and objective cognitive functioning in multiple sclerosis. Arch Clin 
psychological disorders or substance use and self-reported cognitive failures. 

42. Serra-Blasco M, Torres IJ, Vicent-Gil M, et al. Discrepancy between objective 
disorder. Euro 
in major 



and 
Neuropsychopharmacol 2019; 29: 46-56. 
43. Eisenberg IW, Bissett PG, Enkavi AZ, Li J, MacKinnon D, Marsch L, Poldrack 
R. Uncovering the structure of self-regulation through data-driven ontology 
discovery. Nat Comms 2019; 10: 2319. 

 
 
 
 
 
 
 
 
 
 
 
44. Amariglio RE, Buckley RF, Mormino EC, et al. Amyloid-associated increases 
in longitudinal report of subjective cognitive complaints. Alzheimer's & 
Dementia: Translational Research & Clinical Interventions 2018; 4: 444-9. 
45. Mitchell AJ, Beaumont H, Ferguson D, Yadegarfar M, Stubbs B. Risk of 
dementia and mild cognitive impairment in older people with subjective 
memory complaints: meta‐analysis. Acta Psychiatrica Scandinavica 2014; 
130: 439-51. 



47. Vignola A, Lamoureux C, Bastien CH, Morin CM. Effects of chronic insomnia 
and use of benzodiazepines on daytime performance in older adults. J 
Gerontol Series B 2000; 55: P54-62. 
A ccepted M anuscript 


short sleep duration is associated with deficits in neuropsychological 
performance: a general population study. Sleep 2010; 33: 459-65. 
Buela-Casal G. Cognitive-behavioral 
trial. J Health Psychol 2011; 16: 770-782. 
136-144. 
17: 335-43. 



 
 
 
51. Miro E, Lupianez J, Martinez MP, Sanchez AI, Diaz-Piedra C., Guzman MA, 
improves 
attentional function in fibromyalgia syndrome: A pilot, randomized controlled 
52. Cassidy-Eagle E, Siebern A, Unti L, Glassman J & O’Hara R. 
Neuropsychological functioning in older adults with mild cognitive impairment 
and insomnia randomized to CBT-I or control group. Clin Gerontolo 2018; 41: 
50. Altena E, Van Der Werf YD, Strijers RL, Van Someren EJ. Sleep loss affects 
vigilance: effects of chronic insomnia and sleep therapy. J Sleep Res 2008; 
53. Sun J, Kang J, Wang P, Zeng H. Self-relaxation training can improve sleep 
quality and cognitive functions in the older: a one-year randomised controlled 
trial. J Clin Nurs 2013; 22: 1270-1280. 

cognitive performance are associated with changes in sleep in older adults 
with insomnia. Behav Sleep Med 2016; 14: 295-310. 

 
 
 
 
 
 
 
 
 
 


treatment for insomnia in older adults: examination of sleep, mood, and 
cognitive outcomes. Sleep Med 2018; 51: 153-66. 
56. Mitchell L, Bisdounis L, Ballesio A, Omlin X, Kyle SD. The impact of cognitive 
behavioural therapy for insomnia on objective sleep parameters: A meta- 
analysis and systematic review. Sleep Med Rev 2019; 47:90-102. 
57. Ballesio A, Aquino M, Feige B, et al. The effectiveness of cognitive- 
behavioural therapy for insomnia on depression and fatigue symptoms: A 
systematic review and network meta-analysis. Sleep Med Rev 2018; 37: 114- 
129. 
58. Vgontzas AN, Fernandez-Mendoza J, Liao D, Bixler EO. Insomnia with 
objective short sleep duration: the most biologically severe phenotype of the 
disorder. Sleep Med Rev 2013; 17: 241-254. 
A ccepted M anuscript 
 
 
 
 
 
 






A ccepted M anuscript 
 
 
 

able 1. Descriptive characteristics of sample 
Age, years 
Characteristica 
Mean (SD) 
Median, IQR 
52.5 (11.2) 
53 (46-59) 
52.4 (11.7) 
54 (44-61) 
Male 
Female 
30 (14.6%) 
175 (85.4%) 
25 (12.2%) 
180 (87.8%) 

No 
Yes 
124 (60.5%) 
81 (39.5%) 
44 (21.5%) 
146 (71.2%) 
15 (7.3%) 
48 (23.4%) 
141 (68.8%) 
16 (7.8%) 
White 
Mixed 
Asian 
Caribbean 
Other 
No 
Yes, living together 
Yes, living apart 
200 (97.6%) 
1 (0.5%) 
1 (0.5%) 
1 (0.5%) 
2 (1.0%) 
201 (98.1%) 
1 (0.5%) 
3 (1.5%) 
0 
0 
Full-time employed 
Part-time employed 
Unemployed 
Retired 
Full-time student 
Part-time student 
83 (40.5%) 
47 (22.9%) 
10 (4.9%) 
50 (24.4%) 
3 (1.5%) 
12 (5.9%) 
80 (39.0%) 
55 (26.8%) 
8 (3.9%) 
44 (21.5%) 
6 (2.9%) 
12 (5.9%) 
127 (62.0%) 
78 (38.1%) 


None 
GCSE 
A-Level 
College 
University 
Post-graduate 
6 (2.9%) 
19 (9.3%) 
15 (7.3%) 
34 (16.6%) 
51 (24.9%) 
67 (32.7%) 
3 (1.5%) 
32 (15.6%) 
17 (8.3%) 
34 (16.6%) 
58 (28.3%) 
46 (22.4%) 
Employment status, no (%) 
Age when finished education, 
mean (SD) in years 
 

Highest level of qualification, 
no (%) 
Other 
13 (6.3%) 
15 (7.3%) 
Abbreviations: dCBT, digital Cognitive Behavioural Therapy; GSCE, General Certificate for Secondary Education; IQR, interquartile 
range; no, number of participants; SD, standard deviations; WLC, wait-list control. 
a Percentages not adding up to 100% include missing values 
b Response to the following questions: “Are you… Male/Female/Non-Binary 






 
 
 
 
 
 
 
 
 











15.4 (2.7) 
12.5 (3.6) 
11.2 (3.8) 
11.9 (3.3) 
14.0 (2.9) 
64.9 (12.1) 








15.5 (2.8) 
13.0 (3.8) 
11.8 (3.7) 
12.2 (3.6) 
13.9 (3.0) 
66.3 (12.7) 

Sleeping pills prescribed by doctor, 
number of nights in last 2 weeks 
Non-prescription 
number of nights in last 2 weeks 
General fatigue sub-scale 
Physical fatigue sub-scale 
Reduced activity sub-scale 
Reduced motivation sub-scale 
Mental fatigue sub-scale 
Total score 
SNAP task: mean RT (msec) response 
for correct 
identification of matched 
cards (pair) 
Digit span task: longest correct string of 
numbers recalled in reverse format 









Symbol-digit substitution task: number 
of correct matches of symbols and digits 
within 1 minute interval 
Visual attention (TRAILS task), mean (SD) 
 
 Cognitive performance 
Working memory, mean (SD) 






TRAILS-A: Number of errors when 
connecting letters (A,B,C..) in sequential 
order 
TRAILS-A: Mean RT (msec) to connect 
letters (A,B,C..) in sequential order 
TRAILS-B: Number of errors when 
connecting letters and numbers (A-1, B- 
2, C-3,..) 
TRAILS-B: Mean RT (msec) to connect 
letters and numbers (A-1, B-2, C-3,..) 























 
 
 
 
 
 
 
 

Pairs matching task, Level 1: Number of 
errors when matching pairs of cards in 
3x4 matrix 
Pairs matching task, Level 2: Number of 
errors when matching pairs of cards in 
4x4 matrix 




Reasoning, mean (SD) 
Fluid Intelligence task: Total number of correct answers 
(in 2 mins) to series of problem-solving questions (/13) 
Abbreviations: BC-CCI, British Columbia Cognitive Complaints Inventory; CFQ, Cognitive Failures Questionnaire; dCBT, digital Cognitive 
Behavioural Therapy; ESS, Epworth Sleepiness Scale; GAD-2, General Anxiety Disorder scale; ISI, Insomnia Severity Index; msec, 
milliseconds; MFI, Multidimensional Fatigue Inventory; PHQ-9, Patient Health Questionnaire; PSQI, Pittsburgh Sleep Quality Index; RT, 
reaction time; SD, standard deviations; WLC, wait-list control 




 
 
 





able 3. Effects of digital Cognitive Behavioural Therapy (dCBT) vs Wait-list Control (WLC) on Primary and 
Secondary Outcomes (self-reported) 
Assessment 
Self-reported cognitive impairment (BC-CCI) 


Adjusted 
difference (95% 
CI) 
Cohen’s d (95% 
CI) 
-3.03 (-3.60, - 
2.47) 
-3.41 (-4.06, - 
2.76) 
-0.86 (-1.02, - 
0.70) 
-0.96 (-1.15, - 
0.78) 














10.65 
(5.12) 
16.19 
(4.33) 
15.49 
(4.84) 
64.54 
(14.19) 
71.30 
(16.07) 
78.05 
(15.12) 
82.44 
(15.87) 
57.86 
(14.94) 
56.28 
(15.33) 
64.74 
(13.72) 
64.19 
(14.16) 
0.91 (0.74, 
1.07) 
0.72 (0.54, 
0.90) 
-0.70 (-0.84, - 
0.56) 
-0.76 (-0.93, - 
0.60) 
-1.57 (-1.78, - 
1.36) 
-1.60 (-1.85, - 
1.35) 
-5.77 (-6.55, - 
4.99) 
-5.88 (-6.80, - 
4.97) 
13.21 (10.81, 
15.61) 
10.45 (7.82, 
13.09) 
-8.67 (-10.42, - 
6.91) 
-9.48 (-11.54, - 
7.43) 
-1.92 (-2.38, - 
1.45) 
-2.03 (-2.56, - 
1.50) 
-1.90 (-2.41, - 
1.38) 
-2.22 (-2.80, - 
1.65) 
-0.69 (-0.86, - 
0.52) 
-0.73 (-0.91, - 
0.54) 
-0.64 (-0.82, - 
0.47) 
-0.75 (-0.95, - 
0.56) 
-1.27 (-1.78, - 
0.76) 
-1.80 (-2.37, - 
1.23) 
-1.71 (-2.20, - 
1.21) 
-1.58 (-2.15, - 
1.00) 
-0.34 (-0.48, - 
0.20) 
-0.48 (-0.64, - 
0.33) 
-0.51 (-0.66, - 
0.36) 
-0.47 (-0.64, - 
0.30) 
15.27 
(2.86) 
15.15 
(3.05) 
13.56 
(3.35) 
13.35 
(3.60) 
12.05 
(3.44) 
11.52 
(3.49) 
13.87 
(3.30) 
13.72 
(3.15) 
12.37 
(4.10) 
12.53 
(4.10) 
11.58 
(4.14) 
11.17 
(4.07) 
10.24 
(3.73) 
10.26 
(3.69) 
11.72 
(3.46) 
11.70 
(3.55) 
























10.43 
(3.81) 

11.51 
(4.00) 
11.09 
(4.11) 
-1.62 (-2.12, - 
1.12) 
-1.61 (-2.15, - 
1.07) 
-0.43 (-0.56, - 
0.30) 
-0.42 (-0.57, - 
0.28) 


-2.00 (-2.55, - 
1.45) 
-2.10 (-2.69, - 
1.51) 
-0.42 (-0.54, - 
0.31) 
-0.44 (-0.57, - 
0.32) 














 
 
 
 
 
 
 
 
 
 
 
 











41.59 
(15.61) 
40.24 
(15.66) 


53.72 
(13.60) 
54.17 
(14.63) 
10.86 
(4.86) 
10.39 
(5.22) 
11.62 (-13.59, - 
9.66) 
-13.72 (-15.90, - 
11.54) 
-0.83 (-0.97, - 
0.69) 
-0.98 (-1.14, - 
0.83) 
-3.58 (-4.37, - 
2.79) 
-3.35 (-4.20, - 
2.51) 
-0.68 (-0.83, - 
0.53) 
-0.64 (-0.80, - 
0.48) 


-0.76 (-1.02, - 
0.49) 
-0.72 (-1.00, - 
0.45) 
-0.39 (-0.53, - 
0.25) 
-0.37 (-0.51, - 
0.23) 
Adjusted odds ratio 
(95% CI) 



0.3245 
0.5891 
0.0084 
0.0010 
12 (7.74%) 
15 (11.0%) 
23 (14.8%) 
17 (12.5%) 
≥ 1 night in past two weeks using prescribed sleep medication 
 Week 10 
 Week 24 
≥ 1 night in past two weeks using non-prescribed sleep remedies 
 Week 10 
 Week 24 



18 (9.94%) 
17 (10.2%) 
0.50 (0.13, 1.98) 
0.35 (0.07, 1.79) 
0.20 (0.06, 0.66) 
0.10 (0.03, 0.39) 
Unadjusted risk ratio 
(95% CI) 
50 (27.6%) 
47 (28.3%) 
Adjusted risk 
ratio 
(95% CI) 
0.38 (0.21, 
0.54) 
0.49 (0.28, 
0.70) 

Number of occasions (%) 

dCBT 

WLC 

 

Abbreviations: CFQ, Cognitive Failures Questionnaire; CI, confidence intervals; dCBT, digital Cognitive Behavioural Therapy; ESS, 
Epworth Sleepiness Scale; GAD-2, General Anxiety Disorder scale; ISI, Insomnia Severity Index; MFI, Multidimensional Fatigue 
Inventory; PHQ-9, Patient Health Questionnaire; PSQI, Pittsburgh Sleep Quality Index; SD, standard deviations; WLC, wait-list control 



 

 

 
 
 
 
 
1.29 (0.69, 
2.40) 
1.80 (0.94, 
3.46) 
1.39 (0.79, 
2.43) 
1.60 (0.40, 
1.86) 




Assessment 
Working memory: Reverse digit span (longest string) 
Unadjusted, Mean (SD) 
control 

Adjusted 
difference (95% 
CI) 
Cohen’s d (95% 
CI) 
able 4. Effects of digital Cognitive Behavioural Therapy (dCBT) vs Wait-list Control (WLC) on Secondary 
Outcomes of Cognitive Performance 





0.11 (-0.06, 
0.29) 
-0.03 (-0.22, 
0.16) 



Simple attention: SNAP task (RT, msec) 
780.96 
(253.49) 
778.24 
(268.03) 

 




-0.09 (-0.25, 
0.07) 
0.04 (-0.13, 
0.22) 
821.47 
(257.92) 
794.17 
(250.14) 
-23.67 (-65.44, 
18.11) 
10.78 (-34.01, 
55.58) 



31896.53 
(9625.50) 
33215.06 
(12085.34) 
32599.15 
(13395.06) 
54309.98 
(19851.06) 
30394.71 
(11042.08) 
0.03 (-0.12, 
0.17) 
-0.01 (-1.14, 
0.13) 
23.38 
(5.38) 
23.56 
(5.30) 
23.09 
(4.84) 
22.45 
(5.49) 
-0.04 (-0.18, 
0.10) 
0.09 (-0.05, 
0.24) 
359.48 (- 
1749.11, 
2468.07) 
-91.93 (-2048.25, 
1864.40) 
0.05 (-0.09, 
0.19) 
0.04 (-0.11, 
0.19) 
Adjusted odds 
ratio 
(95% CI) 
-571.05 (- 
3542.61, 
2400.52) 
-1014.27 (- 
45850.75, 
2557.21) 
0.01 (-0.17, 
0.19) 
-0.08 (-0.24, - 
0.08) 



-0.04 (-0.19, 
0.11) 
-0.02 (-0.15, 
0.10) 

55063.24 
(25598.13) 
54983.64 
(24939.50) 
55189.32 
(18971.95) 



Number of participants (%) 

dCBT 

WLC 






























Abbreviations: CI, confidence intervals; dCBT, digital Cognitive Behavioural Therapy; msec, milliseconds; RT, reaction time; SD, 
standard deviations; WLC, wait-list control 








 


 
 
 
 
 
 
 
 
 
 
 
 

Mediation, 
% 


able 5. The mediating effects of insomnia symptoms (10 weeks) on self-reported cognitive impairment 
(24 weeks) 


BC-CCI 
(week 24) 
BC-CCI 
(week 24) 








-3.43 
(0.31) 
-1.01 
(0.15) 
-2.35 
(0.35) 
-3.45 
(0.32) 
-2.08 
(0.22) 
-1.29 
(0.34) 
Effect 
size 
(SE) 
Effect 
size 
(SE) 
Effect 
size 
(SE) 
Mediation 
tested 
Sleep 
efficiency 
(week 10) 
Total effect 

Direct effect 

Indirect effect 

p-value 

p-value 

p-value 

 

 

 

 

 

 

 
 
 
 
